On June 19th, Immusmol hosted a webinar about midbrain organoid models of Parkinson’s disease. Prof. Jens Christian Schwamborn (LCSB / OrganoTherapeutics) presented his team’s recently published work, describing a novel patient-derived organoid model of Parkinson’s disease.

In this 30-minute webinar, Prof. Schwamborn discussed this publication, explaining how this model was generated and which endpoints were examined — including dopamine release measured by ELISA — to assess physiological relevance.

Learn more:

• About the work of Jens Christian Schwamborn: LSCB team / OrganoTherapeutics (co-founded in 2019)
• Immusmol’s dopamine ELISA kit used to quantify dopamine release in midbrain organoids
• About neurotransmitter imaging with Immusmol’s primary antibodies to dopamine, serotonin, GABA, Glutamate, and more.